Balloon catheters market to hit $7.6b by 2032

It is driven by advancements in material science and miniaturisation.

The global balloon catheters market, valued at $4.4b in 2023, is projected to grow at a 6.4% CAGR, reaching $7.6b by 2032, according to ResearchAndMarkets.com.

Growth is fuelled by advancements in material science, miniaturisation, and drug-eluting technologies, with a surge in patent activity reflecting industry innovation.

Patent filings are also accelerating as companies focus on improving flexibility, drug delivery, and catheter performance.

Asia-Pacific is emerging as a key player, with 480 historical and 210 ongoing patents, driven by increasing healthcare demand and investment in catheter technology.

Balloon catheters, essential in treating conditions such as coronary artery disease and peripheral vascular disease, continue to evolve with a focus on durability, flexibility, and enhanced drug delivery mechanisms.

The report noted that over 300 patents focus on new materials and coatings, such as hydrophilic coatings and drug-eluting balloons, to improve catheter durability and performance.

Additionally, more than 250 patents are aimed at miniaturisation, enhancing flexibility and navigation through complex vascular pathways.

Drug-eluting technology is another major area of development, with over 200 patents focusing on improved drug delivery for vascular treatments.